The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
Objectives: Doxorubicin (DOXR) belongs to the antineoplastic anthracycline antibiotic and despite its prevalent use for various types of cancer, it is associated with side effects that occur even after treatment cessation, particularly on the heart, blood, liver and kidney. This study aimed to study...
Guardado en:
Autores principales: | Ahlam M. Alhusaini, Abeer M. Alanazi, Laila M. Fadda, Qamraa H. Alqahtani, Wedad S. Sarawi, Iman H. Hasan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e7b4f8b1900643a0945d6106ac0f70c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mokko Lactone Attenuates Doxorubicin-Induced Hepatotoxicity in Rats: Emphasis on Sirt-1/FOXO1/NF-κB Axis
por: Alaa Sirwi, et al.
Publicado: (2021) -
Resveratrol in prevention and treatment of common clinical conditions of aging
por: M Andrea Markus, et al.
Publicado: (2008) -
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang L, et al.
Publicado: (2019) -
Ferruginol Restores SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis and Fatty Acid Oxidation for the Treatment of DOX-Induced Cardiotoxicity
por: Weili Li, et al.
Publicado: (2021) -
Protective Effect of Resveratrol Against Morphine Damage to Kidneys of Mice
por: Jalili,Cyrus, et al.
Publicado: (2017)